Follow
Hicham Skali, MD, MSc
Hicham Skali, MD, MSc
Brigham and Women's Hospital
Verified email at post.harvard.edu
Title
Cited by
Cited by
Year
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
SD Solomon, N Anavekar, H Skali, JJV McMurray, K Swedberg, S Yusuf, ...
Circulation 112 (24), 3738-3744, 2005
8612005
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction
LAM Zornoff, H Skali, MA Pfeffer, M St. John Sutton, JL Rouleau, ...
Journal of the American College of Cardiology 39 (9), 1450-1455, 2002
5892002
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis
R Blankstein, M Osborne, M Naya, A Waller, CK Kim, VL Murthy, ...
Journal of the American College of Cardiology 63 (4), 329-336, 2014
5342014
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis
H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ...
Journal of clinical Oncology 32 (22), 2380, 2014
5062014
Two‐Dimensional Assessment of Right Ventricular Function: An Echocardiographic–MRI Correlative Study
NS Anavekar, D Gerson, H Skali, RY Kwong, E Kent Yucel, SD Solomon
Echocardiography 24 (5), 452-456, 2007
4322007
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM …
S Kenchaiah, SJ Pocock, D Wang, PV Finn, LAM Zornoff, H Skali, ...
Circulation 116 (6), 627-636, 2007
4022007
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
SD Solomon, H Skali, NS Anavekar, M Bourgoun, S Barvik, JK Ghali, ...
Circulation 111 (25), 3411-3419, 2005
3282005
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program
SD Solomon, D Wang, P Finn, H Skali, L Zornoff, JJV McMurray, ...
Circulation 110 (15), 2180-2183, 2004
3122004
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
D Aguilar, SD Solomon, L Køber, JL Rouleau, H Skali, JJV McMurray, ...
Circulation 110 (12), 1572-1578, 2004
3092004
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
A Verma, A Meris, H Skali, JK Ghali, JMO Arnold, M Bourgoun, ...
JACC: Cardiovascular Imaging 1 (5), 582-591, 2008
3012008
Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction
P Jose, H Skali, N Anavekar, C Tomson, HM Krumholz, JL Rouleau, ...
Journal of the American Society of Nephrology 17 (10), 2886-2891, 2006
2812006
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)
NS Anavekar, H Skali, M Bourgoun, JK Ghali, L Kober, AP Maggioni, ...
The American journal of cardiology 101 (5), 607-612, 2008
2632008
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement …
MP Tokmakova, H Skali, S Kenchaiah, E Braunwald, JL Rouleau, ...
Circulation 110 (24), 3667-3673, 2004
2432004
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
AC Pouleur, E Barkoudah, H Uno, H Skali, PV Finn, SL Zelenkofske, ...
Circulation 122 (6), 597-602, 2010
2262010
Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism
T Scridon, C Scridon, H Skali, A Alvarez, SZ Goldhaber, SD Solomon
The American journal of cardiology 96 (2), 303-305, 2005
2182005
Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with …
MT Osborne, EA Hulten, A Singh, AH Waller, MS Bittencourt, GC Stewart, ...
Journal of Nuclear Cardiology 21 (1), 166-174, 2014
2152014
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction
AM Murcia, CH Hennekens, GA Lamas, M Jiménez-Navarro, JL Rouleau, ...
Archives of internal medicine 164 (20), 2273-2279, 2004
1982004
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction …
D Castagno, H Skali, M Takeuchi, K Swedberg, S Yusuf, CB Granger, ...
Journal of the American College of Cardiology 59 (20), 1785-1795, 2012
1872012
Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet …
H Skali, H Uno, AS Levey, LA Inker, MA Pfeffer, SD Solomon
American heart journal 162 (3), 548-554, 2011
1652011
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation
MT Osborne, EA Hulten, VL Murthy, H Skali, VR Taqueti, S Dorbala, ...
Journal of Nuclear Cardiology 24 (1), 86-99, 2017
1642017
The system can't perform the operation now. Try again later.
Articles 1–20